Ex-Meta AI chief LeCun's startup raises $1B seed
Wall Street Breakfast
00:00
Vertex posts strong kidney drug trial results
Kim Kahn notes Vertex is the top S&P gainer after encouraging phase 3 kidney treatment results.
Play episode from 02:32
Transcript
